Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-Ay mice

Cytotechnology

Volumn 67, Issue 4, 2015, Pages 699-710

  Kamakura, Remi ^a   Son, Myoung Jin ^a   de Beer, Dalene ^b   Joubert, Elizabeth ^b,c   Miura, Yutaka ^a   Yagasaki, Kazumi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b AGRICULTURAL RESEARCH COUNCIL   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

AMPK; GLUT4; Hyperglycemia; L6 myotube; RIN 5F cell; Rooibos

Indexed keywords

ADENYLATE KINASE; ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; ASPALATHUS LINEARIS EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PLANT EXTRACT; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; ASPALATHUS; ASPALATHUS LINEARIS; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROMOTER REGION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ASPALATHUS LINEARIS; MUS;

EID: 84931574332     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-014-9816-y     Document Type: Article

References (43)

1. Alderman MH, Cohen H, Madhavan S (1999) Diabetes and cardiovascular events in hypertensive patients. Hypertension 33:1130–1134
2. Beelders T, Sigge GO, Joubert E, de Beer D, de Villiers A (2012a) Kinetic optimisation of the reversed phase liquid chromatographic separation of rooibos tea (Aspalathus linearis) phenolics on conventional high performance liquid chromatographic instrumentation. J Chromatogr A 1219:128–139
3. Beelders T, Kalili K, Joubert E, de Beer D, de Villiers A (2012b) Comprehensive two-dimensional liquid chromatographic analysis of rooibos (Aspalathus linearis) phenolics. J Sep Sci 35:1808–1820
4. Bucala R, Vlassara H (1995) Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26:875–888
5. Cai E, Lin J-K (2009) Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells. J Agric Food Chem 57:9817–9827
6. Cheong SH, Furuhashi K, Ito K, Nagaoka M, Yonezawa T, Miura Y, Yagasaki K (2014a) Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice. Mol Nutr Food Res 58:267–277
7. Cheong SH, Furuhashi K, Ito K, Nagaoka M, Yonezawa T, Miura Y, Yagasaki K (2014b) Daidzein promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and improves glucose homeostasis in Type 2 diabetic model mice. J Nutr Biochem 25:136–143
8. Fiorentino TV, Prioletta A, Zuo P, Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19:5695–5703
9. Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA (2002) Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab 282:E18–E23
10. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
11. Ha BG, Nagaoka M, Yonezawa T, Tanabe R, Woo JT, Kato H, Chung UI, Yagasaki K (2012) Regulatory mechanism for the stimulatory action of genistein on glucose uptake in vitro and in vivo. J Nutr Biochem 23:501–509
12. Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG, Brownlee M, Schleicher ED (1999) Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42:728–736
13. Hernández-Mijares A, Bañuls C, Peris JE, Monzó N, Jover A, Bellod L, Victor VM, Rocha M (2013) A single acute dose of pinitol from a naturally-occurring food ingredient decreases hyperglycaemia and circulating insulin levels in healthy subjects. Food Chem 141:1267–1272
14. Huang S, Czech MP (2007) The GLUT4 glucose transporter. Cell Metab 5:237–252
15. Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW (2002) AICAR administration causes an apparent enhancement of muscle and liver insulin resistant high-fat-fed rats. Diabetes 51:2886–2894
16. Joubert E (1996) HPLC quantification of the dihydrochalcones, aspalathin and nothofagin in rooibos tea (Aspalathus linearis) as affected by processing. Food Chem 55:403–411
17. Joubert E, Manley M, Botha M (2008) Evaluation of spectrophotometric methods for screening of green rooibos (Aspalathus linearis) and green honeybush (Cyclopia genistoides) extracts for high levels of bio-active compounds. Phytochem Anal 19:169–178
18. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010:453892
19. Kawano A, Nakamura H, Hata S, Minakawa M, Miura Y, Yagasaki K (2009) Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice. Phytomedicine 16:437–443
20. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K (2005) Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 20:1647–1658
21. Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463–466
22. Mazibuko SE, Muller CJF, Joubert E, de Beer D, Johnson R, Opoku AR, Louw J (2013) Amelioration of palmitate-induced insulin resistance in C2C12 muscle cells by rooibos (Aspalathus linearis). Phytomedicine 20:813–819
23. Mendis E, Kim MM, Rajapakse N, Kim SK (2007) An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides. Life Sci 80:2118–2127
24. Minakawa M, Kawano A, Miura Y, Yagasaki K (2011) Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells. J Clin Biochem Nutr 48:237–244
25. Minakawa M, Miura Y, Yagasaki K (2012) Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem Biophys Res Commun 422:469–475
26. Muller CJF, Joubert E, de Beer D, Sanderson M, Malherbe CJ, Fey SJ, Louw J (2012) Acute assessment of an aspalathin-enriched green rooibos (Aspalathus linearis) extract with hypoglycemic potential. Phytomedicine 20:32–39
27. Muller CJF, Joubert E, Pheiffer C, Ghoor S, Sanderson M, Chellan N, Fey SJF, Louw J (2013) Z-2-(β-d-glucopyranosyloxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity. Mol Nutr Food Res 57:2216–2222
28. Nishiumi S, Ashida H (2007) Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci Biotechnol Biochem 71:2343–2346
29. Ojuka EO (2004) Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 63:275–278
30. Rabe C, Steenkamp JA, Joubert E, Burger JFW, Ferreira D (1994) Phenolic metabolites from rooibos tea (Aspalathus linearis). Phytochemistry 35:1559–1565
31. Robertson RP, Zhou H, Zhang T, Harmon JS (2007) Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in Type 2 diabetes. Cell Biochem Biophys 48:139–146
32. Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, Alessi DR (2005) Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24:1810–1820
33. Saltiel AR, Kahn CR (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799–806
34. Sezik E, Aslan M, Yesilada E, Ito S (2005) Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci 76:1223–1238
35. Snijman PW, Joubert E, Ferreira D, Li X-C, Ding Y, Green IR, Gelderblom WCA (2009) Antioxidant activity of the dihydrochalcones aspalathin and nothofagin and their corresponding flavones in relation to other rooibos (Aspalathus linearis) flavonoids, epigallocatechin gallate, and Trolox. J Agric Food Chem 57:6678–6684
36. Son MJ, Minakawa M, Miura Y, Yagasaki K (2013) Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice. Eur J Nutr 52:1607–1619
37. Tan KC, Shiu SW, Wong Y, Tam X (2011) Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes Metab Res Rev 27:488–492
38. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733–1742
39. Towler MC, Hardie DG (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328–341
40. Verdecchia P, Reboldi G, Angeli F, Borgioni C, Gattobigio R, Filippucci L, Norgiolini S, Bracco C, Porcellati C (2004) Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43:963–969
41. Wautier JL, Guillausseau PJ (2001) Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 27:535–542
42. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
43. Yagasaki K, Morisaki N, Kitahara Y, Miura A, Funabiki R (2003) Involvement of protein kinase C activation in l-leucine-induced stimulation of protein synthesis in L6 myotubes. Cytotechnology 43:97–103